https://pharmadevicenews.com/can-vedanta-biosciences-turn-microbiome-therapeutics-into-a-real-prevention-strategy-for-recurrent-cdi-and-resistant-infections/ 2026-04-12T07:41:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-veld-pharmaceuticals-and-chiesi-farmaceutici-are-expanding-rare-disease-therapy-access-in-africa/ 2026-04-13T15:59:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-praxis-precision-medicines-phase-3-ulixacaltamide-data-redefine-the-treatment-pathway-in-essential-tremor/ 2026-04-13T16:13:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-septerna-open-a-new-chapter-in-disease-modifying-hypoparathyroidism-treatment/ 2026-04-13T17:30:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-the-lixte-biotechnology-holdings-and-dostarlimab-study-could-influence-future-ovarian-cancer-trial-design/ 2026-04-13T17:44:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-cellectar-biosciences-inc-is-positioning-clr-125-for-a-differentiated-tnbc-treatment-thesis/ 2026-04-14T15:57:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-actuate-therapeutics-phase-2-survival-data-means-for-pancreatic-oncology/ 2026-04-14T17:13:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-hinge-bio-inc-unlock-a-new-class-of-lupus-b-cell-depletion-therapies/ 2026-04-14T17:29:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-grace-therapeutics-strive-on-data-may-change-in-neurocritical-care/ 2026-04-14T17:43:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-teva-pharmaceutical-industries-ltd-s-home-ground-platform-reshape-schizophrenia-support-beyond-medication/ 2026-04-15T16:55:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-boehringer-ingelheim-and-zai-lab-are-advancing-a-two-pronged-dll3-attack-in-sclc/ 2026-04-15T17:15:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-immutep-limited-convert-orphan-designation-into-a-credible-late-stage-oncology-program/ 2026-04-15T17:39:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-cue-401s-immunology2026-data-could-matter-for-autoimmune-drug-pipelines/ 2026-04-15T17:59:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/caredx-divests-lab-products-for-170m-as-core-transplant-diagnostics-gains-momentum/ 2026-04-16T06:26:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-regenerating-skin-nectar-with-trihex-could-strengthen-galdermas-aesthetics-ecosystem/ 2026-04-16T06:32:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-covalon-technologies-convert-iv-contamination-education-into-adoption-of-valguard-and-covaclear/ 2026-04-16T06:36:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-surgentecs-tilink-navigation-clearance-means-for-surgeons-using-minimally-invasive-si-joint-fusion-systems/ 2026-04-16T07:16:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/SurGenTecs-TiLink-SI-joint-fusion-clearance-shows-why-procedural-ecosystems-now-matter-as-much-as-implants-e1776323772685.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/SurGenTecs-TiLink-SI-joint-fusion-clearance-shows-why-procedural-ecosystems-now-matter-as-much-as-implants-e1776323772685.webp https://pharmadevicenews.com/molgramostim-review-pushed-to-november-what-savaras-fda-delay-means-for-autoimmune-pap/ 2026-04-16T07:23:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-new-j-code-means-for-glaukos-epioxa-launch-and-the-future-of-keratoconus-reimbursement/ 2026-04-16T07:26:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-ampligen-become-a-late-stage-pancreatic-cancer-breakthrough-after-aim-immunotechs-latest-clinical-push/ 2026-04-16T19:25:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-fate-therapeutics-inc-solve-the-conditioning-chemotherapy-problem-in-car-t/ 2026-04-16T19:57:01+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-kura-oncologys-latest-data-reveals-about-resistance-biology-in-kidney-cancer/ 2026-04-17T16:13:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-bioxodes-adaptive-trial-strategy-could-accelerate-approval-timelines-in-stroke-therapeutics/ 2026-04-17T17:30:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-medicus-pharma-ltd-s-skinject-application-signals-for-hedgehog-pathway-driven-cancers/ 2026-04-17T17:54:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-janx014-expands-janux-therapeutics-tumor-activated-platform-strategy-in-prostate-cancer-immunotherapy/ 2026-04-17T18:17:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/aacr-2026-can-zai-labs-zocilurtatug-pelitecan-change-the-treatment-picture-for-small-cell-lung-cancer-brain-metastases/ 2026-04-18T05:44:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Zai-Labs-zocilurtatug-pelitecan-posts-notable-brain-metastasis-activity-at-AACR-2026-e1776491023903.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Zai-Labs-zocilurtatug-pelitecan-posts-notable-brain-metastasis-activity-at-AACR-2026-e1776491023903.webp https://pharmadevicenews.com/agenus-aacr-2026-data-show-immune-reprogramming-signal-in-pd-1-refractory-gastroesophageal-cancer/ 2026-04-18T05:59:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Agenus-reports-Phase-II-survival-signal-for-botensilimab-regimen-in-hard-to-treat-gastroesophageal-cancer-e1776491948717.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Agenus-reports-Phase-II-survival-signal-for-botensilimab-regimen-in-hard-to-treat-gastroesophageal-cancer-e1776491948717.webp https://pharmadevicenews.com/aacr-2026-saga-diagnostics-pushes-pathlight-mrd-deeper-into-metastatic-breast-and-ovarian-cancer/ 2026-04-18T06:04:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/SAGA-Diagnostics-expands-the-Pathlight-story-with-new-metastatic-breast-and-ovarian-cancer-data-e1776492235156.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/SAGA-Diagnostics-expands-the-Pathlight-story-with-new-metastatic-breast-and-ovarian-cancer-data-e1776492235156.webp